
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12509025
[patent_doc_number] => 10000458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Production method of 1, 2, 4-triazole compound
[patent_app_type] => utility
[patent_app_number] => 15/471670
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10986
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471670
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471670 | Production method of 1, 2, 4-triazole compound | Mar 27, 2017 | Issued |
Array
(
[id] => 17089683
[patent_doc_number] => 11117860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Phenyl urea derivatives as n-formyl peptide receptor modulators
[patent_app_type] => utility
[patent_app_number] => 16/090068
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16054
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090068 | Phenyl urea derivatives as n-formyl peptide receptor modulators | Mar 27, 2017 | Issued |
Array
(
[id] => 14485115
[patent_doc_number] => 10329324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Indoline compounds as granzyme B inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/470596
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 40946
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470596
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470596 | Indoline compounds as granzyme B inhibitors | Mar 26, 2017 | Issued |
Array
(
[id] => 18070524
[patent_doc_number] => 11529340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Combination for treating pain
[patent_app_type] => utility
[patent_app_number] => 16/088000
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 38
[patent_no_of_words] => 10631
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088000 | Combination for treating pain | Mar 21, 2017 | Issued |
Array
(
[id] => 16141311
[patent_doc_number] => 10703716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Antibacterial compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/085947
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13655
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085947 | Antibacterial compounds and methods of use thereof | Mar 19, 2017 | Issued |
Array
(
[id] => 12562848
[patent_doc_number] => 10016519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
[patent_app_type] => utility
[patent_app_number] => 15/463059
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7860
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463059
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463059 | 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | Mar 19, 2017 | Issued |
Array
(
[id] => 17307319
[patent_doc_number] => 11208411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Compositions and methods for treating parasitic diseases
[patent_app_type] => utility
[patent_app_number] => 16/085981
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71422
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085981 | Compositions and methods for treating parasitic diseases | Mar 16, 2017 | Issued |
Array
(
[id] => 16312264
[patent_doc_number] => 20200291002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
[patent_app_type] => utility
[patent_app_number] => 16/083972
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083972 | Benzofuran derivatives for the treatment of hepatitis C | Mar 16, 2017 | Issued |
Array
(
[id] => 17095347
[patent_doc_number] => 20210283138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => SUBSTITUTED INDOLE MCL-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/081709
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081709 | Substituted indole Mcl-1 inhibitors | Mar 2, 2017 | Issued |
Array
(
[id] => 11706672
[patent_doc_number] => 20170175171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHODS AND KITS FOR BREAKING EMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 15/449192
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12002
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449192 | Methods and kits for breaking emulsions | Mar 2, 2017 | Issued |
| 15/448398 | VOLTAGE SENSITIVE DYES | Mar 1, 2017 | Abandoned |
Array
(
[id] => 16998331
[patent_doc_number] => 11077113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
[patent_app_type] => utility
[patent_app_number] => 15/999530
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10236
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999530
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999530 | 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes | Feb 16, 2017 | Issued |
Array
(
[id] => 15850465
[patent_doc_number] => 10640498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Compounds
[patent_app_type] => utility
[patent_app_number] => 16/070936
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28655
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 680
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070936 | Compounds | Feb 15, 2017 | Issued |
Array
(
[id] => 11956038
[patent_doc_number] => 20170260188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Tricyclic Compounds as Inhibitors of Immunosuppression Mediated By Tryptophan Metabolization'
[patent_app_type] => utility
[patent_app_number] => 15/434414
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27729
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/434414 | Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization | Feb 15, 2017 | Issued |
Array
(
[id] => 11979463
[patent_doc_number] => 20170283617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels'
[patent_app_type] => utility
[patent_app_number] => 15/433688
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24800
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433688
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/433688 | Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels | Feb 14, 2017 | Issued |
Array
(
[id] => 11851600
[patent_doc_number] => 20170226089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'SUBSTITUTED 1,2,3-TRIAZOLES AS NR2B-SELECTIVE NMDA MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/428710
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 158390
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428710 | Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators | Feb 8, 2017 | Issued |
Array
(
[id] => 13901757
[patent_doc_number] => 20190040083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/074899
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074899 | ANTIBACTERIAL COMPOUNDS | Feb 7, 2017 | Abandoned |
Array
(
[id] => 15147617
[patent_doc_number] => 20190352286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA
[patent_app_type] => utility
[patent_app_number] => 16/073503
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073503 | Benzimidazole derivatives as modulators of ROR-gamma | Jan 26, 2017 | Issued |
Array
(
[id] => 16060953
[patent_doc_number] => 10689408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Bisphosphonic acid compound
[patent_app_type] => utility
[patent_app_number] => 16/073285
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12620
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073285 | Bisphosphonic acid compound | Jan 26, 2017 | Issued |
Array
(
[id] => 13870573
[patent_doc_number] => 20190031627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => A KIND OF ISOTHIAZOLE OXIME ETHER-CONTAINING STROBILURIN DERIVATIVES AND ITS PREPARATION METHODS AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/073089
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073089 | Kind of isothiazole oxime ether-containing strobilurin derivatives and its preparation methods and application | Jan 24, 2017 | Issued |